GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of TRIUMPH — 13 things I got wrong before I got it right — 29 comments in the full submission. View in context.
8.2k
c/trialwatch·submitted 2 years ago by u/pancreatitis_scare

TRIUMPH — 13 things I got wrong before I got it right

Trial Databranch of 5 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with…

Read the full submission and all 29 comments →

This branch

5 comments, started 2 years ago
u/rulebook_rachaelmod · c/meta159 points·2 years ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/ines_castellanos69 points·2 years ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/nhs_waitlist_nUK16 points·2 years ago

absolute risk reduction, not relative risk reduction, that is how you decide

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/iman_castellanos5 points·2 years ago·edited

event rates are more informative than hazard ratios alone

replysharereportpermalink
u/pancreatitis_scareOP3 points·2 years ago

Small correction: the trial was 7 weeks, not 34. Does not change your point but people will quote it.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →